Study: Emerging AI Platform for DBT Shows 23 Percent Increase in Breast Cancer Detection Rate
In a recent video interview, Kathy Schilling, M.D., discussed findings from a study of ProFound AI, an adjunctive artificial intelligence (AI) software for digital breast tomosynthesis (DBT), that demonstrated a 23 percent increase in breast cancer detection in comparison to DBT alone.
In a study involving over 100,000 digital breast tomosynthesis (DBT) screening exams, researchers found the use of ProFoundAI (iCAD), an adjunctive artificial intelligence (AI) software for digital breast tomosynthesis (DBT), increased sensitivity by 5 percent, increased the positive predictive value by 23 percent and increased the breast cancer detection rate by 23 percent for nine fellowship-trained breast radiologists with an average of 22 years of experience.
In a recent interview, Kathy Schilling, M.D., a co-author of the study, conceded a fair amount of surprise with the results.
“We have nine dedicated breast radiologists. That is all we do: mammography and breast imaging studies. We thought we were pretty good. It was really quite interesting and surprising that everyone improved their cancer detection by using the ProFound AI (software),” noted Dr. Schilling, the medical director of the Christine E. Lynn Women’s Health and Wellness Institute at the Boca Raton Regional Hospital in Florida.
Dr. Schilling pointed out these increases were achieved without an increase in recall rate.
“We’re not calling more patients back to find more cancers. We’re actually finding more cancers that we may have missed if we (did not) have the use of the ProFound AI,” added Dr. Schilling, who recently presented the study findings at the European Congress of Radiology.
(Editor’s note: For related content, see “Large Mammography Study Reaffirms Benefits of Digital Breast Tomosynthesis,” “Study: AI Improves Cancer Detection Rate for Digital Mammography and Digital Breast Tomosynthesis” and “FDA Issues Final Rule on National Breast Density Notification for Mammography Reports.”)
In a time of significantly increased imaging volume, Dr. Schilling said the ProFound AI software refocuses radiologists to detecting smaller cancers that may have otherwise gone undetected. In the study, she noted the researchers were diagnosing invasive lobular carcinoma, which commonly presents as architectural distortions, down to three to five millimeters in size.
For more insights from Dr. Schilling, watch the video below.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
